D Penicillamine Market: Chelating Agent Maintaining Relevance in...

σε πρόσθεσε στο Health

2026-07-31 10:40:37 -

D Penicillamine Market: Chelating Agent Maintaining Relevance in Wilson's Disease and Rheumatoid Arthritis

Market Overview The D Penicillamine Market maintains steady demand as this established chelating agent remains a cornerstone therapy for Wilson's disease and continues serving select rheumatoid arthritis patients. D-penicillamine facilitates copper excretion in Wilson's disease and modulates immune responses in autoimmune conditions, despite newer therapeutic alternatives entering these spaces....

0 Σχόλια 0 Μοιράστηκε 4 Views 0 Προεπισκόπηση